DIOBEX INC has a total of 36 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and medical technology are TESORX PHARMA LLC, ABSORPTION PHARMACEUTICALS LLC and BIODELIVERY SCIENCES INT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Norway | 2 | |
#10 | South Africa | 2 | |
#11 | Israel | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Henry Robert R | 23 |
#2 | Green Daniel T | 16 |
#3 | Green Daniel Trevor | 8 |
#4 | Stewart Timothy Andrew | 7 |
#5 | Tse Solomon | 1 |
#6 | Stewart Tim | 1 |
#7 | Green Daniel Trevor Henry Robe | 1 |
#8 | Akers Michael J | 1 |
#9 | Sacha Gregory A | 1 |
#10 | Robert R Henry | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008098212A2 | Extended release formulations of glucagon and other peptides and proteins | |
WO2008042898A2 | Ketoconazole enantiomer in humans | |
US2010280046A1 | Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions | |
WO2007075839A2 | Glucagon injector for emergency treatment of hypoglycemia | |
US2006014670A1 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia | |
MXPA06014970A | Compositions and methods for the prevention and control of insulin-induced hypoglycemia. | |
CA2509755A1 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia | |
ZA200504944B | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |